AFF1 and acute lymphoblastic leukemia: Going forward, the unique, age-related molecular profile of MLL-AF4 infant-ALL defined here can be mined for potential novel targets to specifically treat poor prognosis infant-ALL, and these novel treatments can then be tested in CRISPRMLL-AF4+ ALL.